1. Prognostic value of serum Epstein–Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein–Barr virus DNA
   Ji‐Jin Yao et al, 2017, Cancer Science CrossRef
2. The programmed cell death protein-1/programmed cell death ligand 1 expression, CD3+ T cell infiltration, NY-ESO-1 expression, and microsatellite instability phenotype in primary cutaneous melanoma and mucosal melanoma and their clinical significance and prognostic value: a study of 89 consecutive cases
   Yu Ren et al, 2020, Melanoma Research CrossRef
3. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma
   Wen-Xia Chen et al, 2017, Clinics and Research in Hepatology and Gastroenterology CrossRef
4. Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma
   Lan Li et al, 2017, Disease Markers CrossRef
5. Rta-IgG as a biomarker for diagnosis and post treatment prognostic of nasopharyngeal carcinoma
   Xiao-Feng Xu et al, 2016, Cancer Biomarkers CrossRef
6. Autoantibody Signatures Combined with Epstein–Barr Virus Capsid Antigen-IgA as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma
   Yu-Hui Peng et al, 2015, Cancer Prevention Research CrossRef
7. Development of a time-resolved fluoroimmunoassay for Epstein–Barr virus viral capsid antigen IgA antibody in human serum
   Qian-Ni Liang et al, 2015, Journal of Virological Methods CrossRef
8. Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma
   Lie-Hao Lin et al, 2017, Clinical Proteomics CrossRef